A Biopharmaceutical Boost for Infertility
November 19, 2025
Infertility treatments have traditionally placed the burden on women. Antibody-based therapies could redistribute the responsibility and bring new hope for couples.
4 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
FOYA: Celebrating Innovation in Pharma Facilities
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
Latest News
All the latest Medicine Maker articles.
Intranasal H5 Vaccine Sparks Broad Immune Response Across Diverse Avian Flu Strains
November 13, 2025
Phase I trial finds intranasal, adjuvanted recombinant H5 influenza vaccine primes strong mucosal and systemic immunity – subsequent injection boost yields cross-clade protection against multiple H5N1 viruses.
1 min read
Swallowing Safely: Evidence-Based Approaches to Tablets and Dysphagia
November 13, 2025
In stroke patients with dysphagia, the default practice of crushing tablets could increase residue, reduce efficacy, and raise aspiration risk. Researchers reveal how individualized FEES assessments can transform medication safety at the bedside.
5 min read
Kindeva at CPHI Frankfurt 2025: Interviewing Milton Boyer
November 13, 2025
We get the lowdown on Kindeva’s new, multi-use facility in Bridgeton and trends in the market.
Taking on the Genetic Nonsense with tRNAs
November 12, 2025
Engineered tRNAs are redefining precision RNA therapeutics, restoring protein function in diseases caused by nonsense mutations, and bridging the gap between RNA and gene editing technologies.
5 min read
This Week’s Biopharma News: Clinical Hold for Heart Disease Gene Therapy
November 12, 2025
Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly
4 min read
Advancing Gene Therapy for Canavan Disease
November 11, 2025
Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach
3 min read
Promising Early Results in Solid Tumor Trial
November 11, 2025
Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors
2 min read
Smarter Cell Line Development for Better Biologics with AI
November 11, 2025
Drug manufacturing is under pressure as biologics become more complex. To simplify progress, cell line development is evolving with AI and automation.
7 min read
Malaria Vaccine Development: Oxford and ReciBioPharm Extend Manufacturing Deal
November 10, 2025
Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria
4 min read
Breaking Down the Data Walls
November 10, 2025
Pharma must break down data silos to power autonomy, speed, and improved product quality.
3 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.